Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-14-069948

Options or other derivatives

  • Director acquired 28,658 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rubin Steven D · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2014-11-18 Grant or award : show line 1 in the form Common Stock Option (right to buy) +25,344 25,344 D
2014-11-18 Grant or award : show line 2 in the form Common Stock Option (right to buy) +3,314 $0.42 $1,392 28,658 D
Loading xslF345X03/form471637_20141120093401-.xml…